SGCA
AGN

Steel Grove Capital Advisors’s Allergan plc AGN Stock Holding History

Steel Grove Capital Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-3,701
Closed -$900K – 298
2017
Q2 		$900K Sell
3,701
-2,215
-37% -$520K 0.16% 121
2017
Q1 		$1.41M Buy
5,916
+203
+4% +$47.3K 0.25% 84
2016
Q4 		$1.2M Buy
+5,713
New +$1.18M 0.24% 86

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Steel Grove Capital Advisors's AGN Position: Q3 2017 in Review

Steel Grove Capital Advisors sold out of Allergan plc (AGN) in Q3 2017, closing a stake of 3,701 shares — an estimated $900K sold.

Steel Grove Capital Advisors first reported a position in AGN in Q4 2016 and held it in 3 quarters. The position peaked at $1.41M in Q1 2017. 1,090 funds tracked by Wall St. Rank hold AGN as of Q3 2017.

  • Steel Grove Capital Advisors reported no remaining Allergan plc position as of Q3 2017 after selling out during the quarter.
  • Steel Grove Capital Advisors sold 3,701 Allergan plc shares in Q3 2017, an estimated $900K.
  • Steel Grove Capital Advisors first reported a position in Allergan plc in Q4 2016 and held it in 3 quarters.
  • Steel Grove Capital Advisors's Allergan plc position peaked at $1.41M in Q1 2017.
  • 1,090 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on Steel Grove Capital Advisors's 13F filing for Q3 2017, filed 15 Nov 2017.